January 05, 2026
According to market projections, the CRISPR gene editing sector is expected to grow from USD 4.76 billion in 2025 to USD 18.89 billion by 2035, reflecting a CAGR of 14.77%. In 2024, North America led the CRISPR gene editing market, while Asia-Pacific...
November 01, 2025
According to market projections, the genome editing sector is expected to grow from USD 9.39 billion in 2024 to USD 44.95 billion by 2034, reflecting a CAGR of 16.95%. Applications in various industries promote the growth of the genome editing market...
November 01, 2025
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...
January 12, 2026
According to market projections, the CRISPR sector is expected to grow from USD 3.27 billion in 2025 to USD 9.49 billion by 2035, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders ...
November 01, 2025
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering,...
October 08, 2025
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the ...
October 07, 2025
Market insights predict, the Europe biotechnology industry is expected to grow from USD 418.76 billion in 2024 to USD 1208.75 billion by 2034, driven by a CAGR of 11.30%. The presence of a robust biotech hub is driving the Europe biotechnology market...
November 01, 2025
The rising prevalence of chronic disorders and advancements in genomic technologies bolster market growth. North America led the global market owing to the growing demand for biologics and the presence of key players....
December 26, 2025
The gene-editing therapeutics market is expanding due to growing advancements in gene editing technologies as well as their increasing applications. North America led the market due to the presence of the largest cluster of sponsors. ...
November 12, 2025
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing...
January 21, 2026
Based on our estimations, the U.S. Cell and Gene Therapy CRO market was valued at USD 2.33 billion in 2025 and is projected to grow from USD 2.56 billion in 2026 to USD 6.02 billion by 2035, registering a CAGR of 9.95% during 2026–2035....
December 15, 2025
The global gene therapy platform market size was estimated at USD 2.25 billion in 2025 and is predicted to increase from USD 2.59 billion in 2026 to approximately USD 9.29 billion by 2035, expanding at a CAGR of 15.23% from 2026 to 2035. The gene the...
November 01, 2025
The growing demand for gene therapy and stringent regulatory policies drive the global market. North America dominated the market due to its favorable clinical trial infrastructure and new product launches....
November 27, 2025
Projections indicate that, the global AAV manufacturing service market will increase from USD 1.44 billion in 2025 to USD 6.25 billion by 2035, experiencing a CAGR of 15.84% over the next 10 years. The critical importance of adeno-associated virus fo...
November 26, 2025
Based on market forecasts, the cell & gene therapy logistics sector will expand from USD 6.41 billion in 2025 to USD 43.14 billion by 2035, experiencing a CAGR of 21%. The cell & gene therapy logistics market is growing because it provides ma...
November 01, 2025
Gene expression involves converting genetic information into functional RNA or proteins, vital in healthcare for disease insights and drug discovery. North America leads the market, driven by funding and advancements, while Asia-Pacific grows rapidly...
November 04, 2025
Based on market forecasts, the global gene vector market, projected at USD 9.61 billion in 2025, is expected to reach USD 64.38 billion by 2035, growing at a CAGR of 21% over the forecast period. The gene vector market is growing due to rising demand...
November 01, 2025
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell mode...
November 01, 2025
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 4.90 billion in 2024 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs wor...
November 01, 2025
Market insights predict, the cell and gene overexpression service industry is expected to grow from USD 771.40 million in 2024 to USD 1,192.24 million by 2034, driven by a CAGR of 4.45%. The cell and gene overexpression service market is expanding du...
November 01, 2025
The global market is driven by a rise in SCD prevalence and R&D activities. North America dominated the market due to the increasing R&D investment from various companies....
November 01, 2025
The market is expanding due to the increasing prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, and epilepsy. Advancements in neuroimaging biomarkers and novel drug development are further driving trial growth....
January 07, 2026
Projections indicate that, the Cell and Gene Therapy Services Market was valued at USD 10.79 billion in 2025 and is projected to grow from USD 11.84 billion in 2026 to USD 27.16 billion by 2035, registering a CAGR of 9.67% during 2026–2035. The...
November 01, 2025
Market insights predict the global cell and gene therapy thawing equipment industry will increase from USD 0.96 billion in 2024 to USD 3.56 billion by 2034, achieving a CAGR of 14.24%. The Cold-chain expansion for CGT is estimated to drive the growth...
November 01, 2025
Based on market forecasts, the global viral vector gene therapy market, projected at USD 13.14 billion in 2024, is expected to reach USD 38.39 billion by 2034, growing at a CAGR of 11.23% over the forecast period. The viral vector gene therapy market...
November 12, 2025
Projections indicate that, the global viral vector manufacturing market will increase from USD 1.82 billion in 2025 to USD 12.91 billion by 2035, experiencing a CAGR of 21.64% over the next 10 years. The market is growing due to rising demand for gen...
October 08, 2025
Projections indicate that, APAC cell and gene therapy industry is projected to rise from USD 4.59 billion in 2024 to USD 39.62 billion by 2034, reflecting a CAGR of 24.04% over the next decade. A surge in wider demand for advanced therapies due to ri...
November 01, 2025
Projections indicate that, the global cell and gene therapy cold chain logistics market will increase from USD 1.89 billion in 2024 to USD 8.06 billion by 2034, experiencing a CAGR of 15.64% over the next 10 years. The cell and gene therapy cold chai...
November 01, 2025
Market insights predict the global cell and gene therapy isolator industry will increase from USD 1.35 billion in 2024 to USD 4.47 billion by 2034, achieving a CAGR of 12.54%. The growing demand for cell and gene therapy products and technological ad...
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as ...
December 22, 2025
According to market projections, the global endonucleases market, valued at USD 394.3 million in 2025, is anticipated to reach USD 963.86 million by 2035, growing at a CAGR of 9.35% over the next decade.The endonucleases market is increasing rapidly,...
October 08, 2025
Projections indicate that, the Middle East and Africa cell and gene therapy market will increase from USD 1.15 billion in 2024 to USD 9.75 billion by 2034, experiencing a CAGR of 23.85% over the next 10 years. The burgeoning biotechnology sector and ...
November 01, 2025
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral ...
November 01, 2025
According to market projections, the gene therapy cell culture media sector is expected to grow from USD 193.45 billion in 2024 to USD 541.42 billion by 2034, reflecting a CAGR of 10.84%. The market is growing due to rising demand for efficient gene-...
January 08, 2026
Projections indicate that, the global gene prediction tools market will increase from USD 237.44 million in 2025 to USD 1320.67 million by 2035, experiencing a CAGR of 18.72% over the next 10 years. Currently, the respective market is driven by the a...
November 01, 2025
The market is growing due to the demand for safe and efficient delivery of advanced cell and gene therapies. Technological innovations and increasing clinical adoption are accelerating the market’s expansion in North America....
November 01, 2025
Projections indicate that, the global cell & gene therapy (CGT) biomanufacturing market will increase from USD 14.03 billion in 2024 to USD 41.41 billion by 2034, experiencing a CAGR of 11.43% over the next 10 years. Increasing outsourcing & ...
December 19, 2025
Market insights predict the global gene therapy industry will increase from USD 9.5 billion in 2024 to USD 58.87 billion by 2034, achieving a CAGR of 20%. The gene therapy market is growing rapidly due to the growing demand for precision medicine. No...
November 01, 2025
The cell and gene therapy manufacturing market size is calculated at $5.9 bn in 2025 is to hit $22.88 bn by 2034. In 2024, North America led the cell and gene therapy manufacturing market, with Asia-Pacific expected to grow the fastest. Allogeneic ce...
November 01, 2025
Market insights predict the global gene synthesis industry will increase from USD 2.44 billion in 2024 to USD 10.89 billion by 2034, achieving a CAGR of 16.14%. The growing demand for gene therapy and personalized treatments boosts the demand for gen...
January 06, 2026
Market insights predict, the cell and gene therapy manufacturing isolators industry is expected to grow from USD 140.16 Million in 2025 to USD 321.3 million by 2035, driven by a CAGR of 8.65%. The growing demand for personalized medicines and advance...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.0...
October 09, 2025
Market insights predict, the Latin America cell and gene therapy industry is expected to grow from USD 1.15 billion in 2024 to USD 10.19 billion by 2034, driven by a CAGR of 24.40%. The rising prevalence of chronic and genetic diseases is expected to...
November 01, 2025
Based on market forecasts, the global cell and gene supply chain solutions market, projected at USD 3.54 billion in 2024, is expected to reach USD 14.95 billion by 2034, growing at a CAGR of 15.54% over the forecast period. The cell and gene supply c...
January 19, 2026
Forecasts suggest that the cell and gene therapy market will expand USD 232.22 billion by 2035, with a CAGR of 24% during the forecasted period. Gene therapy is rapidly evolving, driven by CRISPR and CAR-T advancements. Once focused on rare diseases ...
October 13, 2025
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending...
November 01, 2025
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene ther...
November 01, 2025
Market insights predict the global RNAi therapeutics industry will increase from USD 1.28 billion in 2024 to USD 5.11 billion by 2034, achieving a CAGR of 14.9%. In 2023, siRNA therapy dominated with a 64% market share, leading the RNA-based treatmen...
November 01, 2025
Based on market forecasts, the global cell and gene therapy manufacturing QC market, projected at USD 2.66 billion in 2024, is expected to reach USD 12.35 billion by 2034, growing at a CAGR of 16.89% over the forecast period. The growing demand for c...
October 13, 2025
According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of ...
November 01, 2025
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patie...
October 14, 2025
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
November 01, 2025
According to forecasts, the global cell and gene therapy bioassay services market will grow from USD 5.05 billion in 2024 to USD 16 billion by 2034, with an expected CAGR of 12.24%. A rise in personalized trends is expanding the global market develop...
November 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share,...
January 02, 2026
Projections indicate that, the global plasmid DNA manufacturing market will increase from USD 2.61 billion in 2025 to USD 14.59 billion by 2035, experiencing a CAGR of 18.77% over the next 10 years. Plasmid DNA is highly valuable in conducting resear...
November 01, 2025
Projections indicate that, the global gene synthesis service market will increase from USD 681.53 million in 2024 to USD 3138.64 million by 2034, experiencing a CAGR of 16.5% over the next 10 years. The rising incidences of chronic disorders, increas...
January 21, 2026
Our projections indicate that, the non-viral gene delivery technologies market covers comprehensive statistical insights including market size valued at USD 4.69 billion in 2026 and projected to reach USD 13.38 billion by 2035, expanding at a CAGR of...
November 01, 2025
According to market projections, the global gene overexpression cell line construction market, valued at USD 788.63 million in 2024, is anticipated to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% over the next decade. The versatilit...
November 01, 2025
The exosome cell and gene therapy market is booming, driven by its use in treating cancer, rare, and genetic diseases. With tech like AI and automation, personalized therapies are improving care. North America leads, while Asia Pacific sees rapid gro...
January 20, 2026
According to our projections, the U.S. cell and gene therapy clinical trials market was valued at USD 5.41 billion in 2025 and is projected to grow from USD 6.26 billion in 2026 to USD 23.14 billion by 2035, registering a CAGR of 15.64% during 2026 t...
December 01, 2025
Based on market forecasts, the global cell and gene therapy third-party logistics market, projected at USD 1.81 billion in 2025, is expected to reach USD 16.95 billion by 2035, growing at a CAGR of 25.05% over the forecast period. The cell and gene t...
October 13, 2025
According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising ...
January 08, 2026
Projections indicate that, the cell and gene therapy supply chain and logistics market report delivers a complete analysis of market size, which stood at USD 1.72 billion in 2025, is projected to reach USD 1.93 billion in 2026, and is forecasted to e...
November 01, 2025
Based on market forecasts, the plasmid purification sector will expand from USD 1.95 billion in 2024 to USD 5.88 billion by 2034, experiencing a CAGR of 11.64%. In 2024, North America led the plasmid purification market with a 41% share, while Asia P...
January 07, 2026
Projections indicate that, the LV-based cell and gene therapy products market was valued at USD 5.48 billion in 2025 and is projected to grow from USD 6.42 billion in 2026 to approximately USD 26.94 billion by 2035, expanding at a CAGR of 17.27% duri...
November 01, 2025
Market insights predict, the gene transfer technologies industry is expected to grow from USD 3.98 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 9.62%. These techniques play a vital role in gene therapy, biotechnology research, a...
January 09, 2026
Our market insight calculates, the cell and gene therapy bioanalytical testing services market was valued at USD 589.08 million in 2025 and is projected to grow from USD 632.55 million in 2026 to USD 1,200.62 million by 2035, registering a CAGR of 7....
November 01, 2025
Market insights predict the global optic nerve atrophy treatment industry will increase from USD 2.53 billion in 2024 to USD 5.87 billion by 2034, achieving a CAGR of 8.85%. The optic nerve atrophy treatment market is growing due to the increasing in...
November 01, 2025
Projections indicate that, the global cell & gene therapy quality control market will increase from USD 2.28 billion in 2024 to USD 22.81 billion by 2034, experiencing a CAGR of 25.74% over the next 10 years.The cell & gene therapy quality co...
November 01, 2025
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy...
January 15, 2026
Our projections indicate that, the global gene knockout cell line construction service market will increase from USD 2.1 billion in 2025 to USD 3.56 billion by 2035, experiencing a CAGR of 5.44% over the next 10 years. Developing disease modeling and...
November 01, 2025
The growing demand for targeted therapeutics and new product launches drives the global market. North America dominated the global market due to the presence of key players and favorable infrastructure....
October 07, 2025
According to market projections, the AAV gene therapy sector is expected to grow from USD 2.75 billion in 2024 to USD 78.56 billion by 2034, reflecting a CAGR of 40.1%. This AAV gene therapy market growth is driven by emerging trends and strong deman...
November 01, 2025
Market insights predict, the gRNA industry is expected to grow from USD 592.66 million in 2024 to USD 3,296.45 million by 2034, driven by a CAGR of 18.72%. Growing research in genomics due to rare diseases and gene and cell therapy drives the use of ...
December 30, 2025
According to market projections, the generic drugs industry is expected to grow from USD 513.02 billion in 2025 to USD 859.84 billion by 2035, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, wh...
November 17, 2025
Market insights predict the global epigenetics industry will increase from USD 19.55 billion in 2025 to USD 81.32 billion by 2034, achieving a CAGR of 15.32%. The decline in sequencing costs, the rise in next-generation sequencing applications worldw...
October 22, 2025
Based on market forecasts, the multiplex PCR kit sector will expand from USD 1.25 billion in 2024 to USD 3.43 billion by 2034, experiencing a CAGR of 10.64%. The Multiplex PCR Kit Market is growing due to its significant applications in diagnosing in...
November 01, 2025
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $...
October 17, 2025
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to...
November 01, 2025
Market insights predicts the genetic material market is set for strong growth from 2025 to 2034, driven by gene therapies, personalized medicine, and biopharma research. North America led in 2024, while Asia Pacific will grow fastest. DNA dominated, ...
November 01, 2025
The molecular cytogenetics market is growing due to the rising demand for cancer diagnosis, congenital syndrome detection, and personalized medicine. Key drivers include advances in genomics, increasing R&D, and government investments. Notable in...
December 05, 2025
Based on market forecasts, the global next generation cancer diagnostics market, projected at USD 19.20 billion in 2025, is expected to reach USD 41.64 billion by 2035, growing at a CAGR of 8.05% over the forecast period. The market is driven by the ...
November 01, 2025
The nerve repair and regeneration market grows with rising nerve injuries from accidents, chronic disorders, and trauma. Companies like Progentos and Neuraptive advance treatments, with Axogen reporting growth in surgical solutions for peripheral ner...
January 19, 2026
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 460.47 billion in 2025 to USD 1026.8 billion by 2035, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and...
January 05, 2026
Based on market forecasts, the collagen fillers market was valued at USD 53.22 million in 2025 and is projected to grow from USD 56.65 million in 2026 to USD 99.34 million by 2035, registering a CAGR of 6.44% during the forecast period. The report pr...
January 16, 2026
Our projections indicate that, U.S. longevity & general wellness supplements industry is projected to rise from USD 6.38 billion in 2025 to USD 11.53 billion by 2035, reflecting a CAGR of 6.1% over the next decade.The growing awareness of longevi...
November 05, 2025
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health ...
November 12, 2025
Market insights predict the global generative AI in life sciences industry will increase from USD 302.05 million in 2025 to USD 1,657.02 million by 2034, achieving a CAGR of 20.82%. Around the world, the generative AI in life sciences market is drive...
December 30, 2025
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity,...
November 01, 2025
The next-generation bispecific antibody market is expanding due to increasing diseases as well as rising autoimmune diseases treatment approaches. North America led the market due to the presence of well-developed industries....
November 03, 2025
Based on market forecasts, the global cell line cryopreservation market, projected at USD 5.39 billion in 2025, is expected to reach USD 13.97 billion by 2034, growing at a CAGR of 11.16% over the forecast period. The cell line cryopreservation marke...
January 06, 2026
Market insights predict, the U.S. next generation sequencing industry is expected to grow from USD 2.85 billion in 2025 to USD 12.52 billion by 2035, driven by a CAGR of 15.95%. The growing demand for personalized medicines and the increasing adoptio...
November 01, 2025
Market insights predict the global animal genetics industry will increase from USD 6.51 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 6.4%. In 2024, North America led the animal genetics market with a 32% share, while Asia-Pacific...
November 01, 2025
The macular edema and macular degeneration market is growing rapidly due to the prevalence of diabetic retinopathy and advancements in treatments like gene therapy and AI-based devices. Innovations, including FDA-approved EYLEA HD and OrCam MyEye, hi...
November 01, 2025
Projections indicate that, the global preimplantation genetics diagnosis (PGD) market will increase from USD 67.79 million in 2024 to USD 144.19 million by 2034, experiencing a CAGR of 7.84% over the next 10 years. The preimplantation genetics diagno...
November 01, 2025
Market insights predict the global U.S. general surgery devices industry will increase from USD 5.69 billion in 2024 to USD 12.89 billion by 2034, achieving a CAGR of 8.53%. The U.S. general surgery devices market is expanding due to growing chronic ...
December 24, 2025
The Market is expanding rapidly as breakthroughs in genetic engineering and precision medicine unlock effective treatments for previously untreatable cancers. Investment in universal CAR-T platforms, combination strategies with checkpoint inhibitor...
January 09, 2026
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.78 billion in 2025 to USD 2.28 billion by 2035, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle syn...
November 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
December 30, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance ...
November 01, 2025
Market insights predict the global scaffold technology industry will increase from USD 2.34 billion in 2024 to USD 8.58 billion by 2034, achieving a CAGR of 13.9%. North America led the market with a 41% share, while the Asia Pacific region is p...
November 07, 2025
Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand f...
November 01, 2025
According to forecasts, the global general surgery devices market will grow from USD 18.44 billion in 2024 to USD 41.57 billion by 2034, with an expected CAGR of 8.54%. The general surgery devices market is expanding due to increasing minimally invas...
November 01, 2025
Market insights predict, the north america next generation sequencing industry is expected to grow from USD 5.08 billion in 2024 to USD 36.87 billion by 2034, driven by a CAGR of 21.93%. North America is growing due to technological advancements and ...
December 30, 2025
According to market projections, the global generative AI in healthcare market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 53.68 billion by 2035, growing at a CAGR of 35.10% over the next decade. Generative AI in healthcare enhan...
December 30, 2025
Market insights predict the global cell harvesting industry will increase from USD 6.71 billion in 2025 to USD 22.68 billion by 2035, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies...
December 23, 2025
Market insights predict, the direct-to-consumer genetic testing industry is expected to grow from USD 2.45 billion in 2024 to USD 21.85 billion by 2034, driven by a CAGR of 24.44%. The direct-to-consumer genetic testing market is expanding due to inc...
November 01, 2025
Market insights predict the global next generation sequencing industry will increase from USD 10.27 billion in 2024 to USD 73.47 billion by 2034, achieving a CAGR of 21.74%. The NGS market is strongly growing because NGS is needed in disease diagnosi...
November 01, 2025
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
October 08, 2025
Projections indicate that, the global generative AI in drug discovery market will increase from USD 250 million in 2024 to USD 2847.43 million by 2034, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market i...
November 01, 2025
The next-generation AI in life sciences market is growing rapidly due to a growing focus on providing high-quality healthcare services in less time. North America’s dominance is attributed to the rising focus on evidence-based healthcare practi...
November 04, 2025
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, t...
November 01, 2025
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
November 01, 2025
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
November 01, 2025
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fas...
November 03, 2025
Based on market forecasts, the microcarriers sector will expand from USD 1.76 billion in 2024 to USD 5.21 billion by 2034, experiencing a CAGR of 11.48%.The microcarriers market is growing due to they are broadly applied in medical regeneration, in...
October 06, 2025
According to forecasts, the global regenerative medicine market will grow from USD 20.09 billion in 2024 to USD 139.70 billion by 2034, with an expected CAGR of 21.4%. North America leads the regenerative medicine market with a 49.21% share. The...
November 01, 2025
According to market projections, the cell culture sector is expected to grow from USD 20.61 billion in 2024 to USD 60.38 billion by 2034, reflecting a CAGR of 11.35%. The increasing incidences of chronic disorders, growing research and development,...
November 01, 2025
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
November 01, 2025
Projections indicate that, the global synthetic tissue engineering market will increase from USD 1.51 billion in 2024 to USD 5.61 billion by 2034, experiencing a CAGR of 14.14% over the next 10 years.The synthetic tissue engineering market is growi...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com